Teva Unloads 15 Generics on Impax

by | Jun 23, 2016 3:54 pm | Pharmaceuticals

To fulfill a condition of its $40.1 billion acquisition of Allergan’s (NYSE: AGN) U.S. generics business, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) agreed to sell a broad portfolio of generic products across solid oral, inhalable, injectable and topical dosage forms to Impax Laboratories Inc. (NASDAQ: IPXL). The $586 million price includes the return to Impax of its rights to its pending Abbreviated New Drug Application (ANDA) for the generic equivalent to Concerta®. Impax is using existing cash and $400 million in new fully committed term loans, provided by RBC Capital Markets. Upon closing, Impax expects to add a portfolio of 15 currently marketed generic products; one... Read More »

New MainStream Adds Constellation Behavioral

by | May 25, 2016 8:00 am | Behavioral Health Care, Private Equity

Constellation Behavioral Health, LLC became the fourth healthcare services company in New MainStream Capital’s portfolio on May 19. Constellation joins Anne Arundel Dermatology, MCCI Medical Group and Suncrest Home Health. Based in Mill Valley, California, Constellation offers specialized inpatient and outpatient treatment programs for addiction, mental health and co-occurring behavioral health disorders. Founder and CEO William Morrison will retain a minority stake. Constellation operates two facilities in California: Alta Mira and Bridges to Recovery. Alta Mira is a 30-bed facility in Sausalito, California with 30,000 square feet. Bridges to Recovery is a 12-bed facility in Los... Read More »